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Summary.-An originally virus-induced, non-producer tumour system has been
studied in relation to humoral and cellular cytotoxic responses to transplantation and
other immunization techniques. In all experimental groups cytotoxic lymphocytes
(CTL) were observed eitherdirectly or after mixed culture oflymphocytes and tumour
cells (MLTC). Except for C'-dependent cytotoxic antibodies in mice immunized by
irradiated cells, no antibody-mediated cytotoxicity was observed. In 2 protocols
(transplantation and immunization by mitomycin-treated cells) CTL in vitro were
not protective. In a third protocol (immunization by irradiated cells) CTL afforded
partial protection and other factors appeared to be involved. The best in vivo pro-
tection was induced by immunization consequent onearly surgical removal of a small
number of transplanted tumour cells. This study provides lines of evidence for the
effectiveness of protection supplied by CTL in well-defined conditions. Comparison
with other modes of immunization indicated that these conditions were related to the
quantity and to the characteristics of antigen involved.
THE EXISTENCE of an immune response
to tumour antigen has been demonstrated
for several animal systems. This response
is most often studied in terms of humoral
parameters (Negroni & Hunter, 1971;
Robertson & Black, 1969) but evidence
for the presence of cytotoxic T lympho-
cytes (CTL) has given rise to a cellular
approach to this same phenomenon. This
approach has been particularly exploited
in viral-murine systems (Levy & Leclerc,
1977) which have demonstrated raised
T-cell cytotoxicity within a syngeneic
context.
However, "little information is avail-
able that would allow one to determine
whether the in vitro phenomena are rele-
vant to in vivo tumour rejection" (Levy &
Leclerc, 1977). The situation is even more
obscure for transplantation of non-pro-
ducer tumour cells. We have studied a
model of this latter type, testing the in
vitro activity of splenocytes and sera from
transplanted mice which had never shown
tumour rejection, as well as from mice
immunized by different techniques. Cor-
relation with in vivo protection was in-
vestigated by the Winn assay and the
challenge inoculation of immunized mice.
We were able to show that, within a
defined context, CTL were capable of
tumour-cell lysis in adoptive transfer, and
lines of evidence suggested that the CTL
were responsible for tumour rejection in
the challenged animal. But in other situa-
tions, in-vitro-effective CTL acted as non-
protectors in vivo. Different responses
were related to different modes of im-
munization. The best circumstance for
an anti-tumour response was associated
with early surgical removal of a small
number of transplanted tumour cells. The
unaltered limited amount of antigen
appeared responsible for the induction of
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effective CTL, whereas transplantation
without surgical removal led to over-
whelming numbers of multiplying tumour
cells, and immunization by irradiated cells
led to a more complex and less protective
response, possibly because of the repeated
injection of modified antigen.
MATERIALS AND METHODS
Experimental system
The animals used in this study were 5-6-
week-old C57BL/6 female mice. Our MBL2
tumour originated from a lymphosarcoma
which was induced by Moloney virus (MSV)
in C57BL/6 females (Glynn et al., 1968). This
line was maintained and continued in its
ascitic form by i.p. injection of 106 viable
MBL2 cells. If 5 x 104 cells were injected s.c.
into the rear thigh, a solid tumour appeared
which was consistently lethal on Days 20-25
after inoculation.
In our laboratory, this line does not appear
to be accompanied by viral propagation. This
was ascertained after inoculating D56 (S+L-)
cells with a cell filtrate from MSV-bearing
MBL2 cells. Since the inoculation did not
result in transformation of the D56 (S+L-)
strain (Prof. C. Jasmin, ICIG, Villejuif,
France) we concluded that the MBL2 cells do
not support propagation of the virus. An
EL4 tumour line derived from benzanthra-
cene-induced lymphoma in C57BL/6 male
mice were used to test the specificity of our
results.
In vitro tests
T-type cytotoxicity.-Target cells were
MBL2 and effector cells were a total spleno-
cyte population containing CTL. The tech-
nique has previously been described by
Cerottini & Brunner (1971) and consists of
incubating splenocytes at different ratios
(10/1 to 100/1) with 104 target cells labelled
with chromium 51 (51Cr-S1, Saclay). This
mixture was incubated for 3 h at 37°C
followed by 1 h at 45°C (Dunkley et al., 1974).
Results are expressed as percentage specific
cytotoxicity + s.d.
Secondary MLTC-CML.-Lymphocytes
which had been sensitized in vivo were subse-
quently stimulated in vitro to produce CTL
in mixed culture with tumour cells (MLTC).
Cultures were carried out in 30ml flasks
(25100 Corning CML) containing 40x 106
splenocytes and 8 x 106 irradiated MBL2
cells (60 Gy, 60Co source, Gammatron III,
Siemens) both of which are suspended in
20 ml of medium previously defined by
Cerottini et al. (1974).
Cytotoxic activity of killer cells (ADCC).-
Target cells were CRBC coated with rabbit
anti-CRBC antibody. Effector cells were the
entire splenocyte population. The technique
was that of Ghaffar et al. (1976). Briefly, 104-
labelled CRBC were coated with anti-CRBC
serum at selected dilution and incubated for
18 h at 37°C with splenic cells in variable
proportions (10/1 to 100/1). Anti-serum was
prepared using the Hunninghake & Fauci
method (1976). Results are expressed as per-
centage specific cytotoxicity± s.d.
Lymphocyte-dependent antibody (LDA).
Before undertaking this test, the absence of
Fc receptor on MBL2 target cells was demon-
strated by the EA-rosette technique which
showed 2-3% rosettes (Thierry et al., 1976).
The LDA technique is the same as that
used to measure K-cell activity, but with the
following modifications for effector and target
cells: target MBL2 cells are coated with test
serum at different dilutions (1/20 to 1/200).
Mouse splenocytes or, even better, human
lymphocytes (which are an excellent source
of K cells, Wyss & Cerottini, 1976) were used
as effector cells. We tried to eliminate false
negative reactions due to Ag-Ab complexes
by pre-incubating the test sera with poly-
ethylene glycol (PEG) (Creighton et al., 1973).
Complement (C')-dependentantibody(C'DA).
-MBL2 target cells were exposed to normal
and experimental mouse serum plus C'
(guinea-pig, Gibco). The test procedure
followed the technique described by Wernet
& Lilly (1975). Briefly, 106 51Cr-labelled
MBL2 cells were incubated at 37°C in test
serum at different dilutions (1/4 to 1/640) in
the presence of C' for a predetermined time
(1, 2 and 3 h). Sera were also tested after
PEG incubation (Creighton et al., 1973).
Results are expressed as percentage specific
cytotoxicity + s.d.
Anti-Thy 1-2.-Anti-Thy 1-2 serum was
prepared according to the technique of
Gorczynski et at. (1972). Briefly, 108 mouse
(C3H) thymocytes in Freund's complete
adjuvant (FCA, Difco) were injected into
AKR mice. This procedure was repeated after
3 and 6 weeks. The specificity of the immune
serum was verified using C57BL/6, BALB/c
and AKR mouse thymocytes in the presence
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ofC' (Leclerc et al., 1973). Anti-Thy 1-2 serum
was used (with C' guinea-pig, Difco) to
identify the cytotoxic T lymphocytes.
Immunization techniques
Table I summarizes the different tech-
niques, with an indication ofthe test schedule.
Amputation.-Mice were anaesthetized and
the leg receiving the inoculum was amputated
before the onset of metastasis. Histopatho-
logical examination established this to be
before Day 20 post-inoculation, though local
ganglia involvement can already be demon-
strated on Day 8. The difficulty with this
procedure is that the tumour-cell inoculum
is injected s.c. and often the tumour will
develop in the inguinal region. It is there-
fore necessary to excise all suspected tissue
(especially local nodes) in order totally to
eliminate the inoculum and prevent tumour
recurrence. 50% of the amputated tumour-
bearing mice survived and showed no
evidence oftumour.
Immunization by i.p. injection of MBL2
cells treated with mitomycin-C (MTC-MBL2).
-The protocol was that of Benjamini et al.
(1977) as modified by Thiery & Serrou (1974)
in order to use the optimal dose ofmitomycin
C (MTC-Ametycine, Choay) necessary to
block MBL2 cells without causing lysis. Cell
multiplication was at its lowest point and cell
mortality was not more than 15% when
20 ,ug of MTC was used to effectively block
106 MBL2 cells suspended in 100 ,ul ofculture
medium. Cell viability was verified by trypan-
blue exclusion.
Immunization by i.p. injection of irradiated
MBL2 cells.-The technique was that de-
scribed by Carlson & Terres (1976). Briefly,
mice were injected s.c. with 5 x 106 MBL2
irradiated cells (100 Gy) in FCA. This
inoculation was followed by 5 i.p. booster
injections also containing 5 x 106 irradiated
MBL2 cells, but no FCA.
In vivo tests
Challenge.-The challenge consisted of s.c.
injection oftumour inoculum into immunized
C57BL/6 females. A lethal tumour con-
sistently appeared in non-immunized mice.
Winn assay.-Cytotoxic T effectors were
transferred according to the Winn assay tech-
nique (1961). Briefly, normal C57BL/6
females are injected with tumour inoculum
plus sensitized mouse splenocytes in different
proportions (30/1; 100/1; 300/1).
RESULTS
Positive cell-mediated cytotoxicity was
obtained in every case. ADCC was equal
in all groups (mice, control, tumoral and
immunized mice) by the various methods.
These observations were therefore re-
garded as uninformative. Humoral cyto-
toxicity was always negative; tests for
LDA antibodies were negative in all cases
studied; for both murine or human effector
cells C'DA antibodies were demonstrated
only after immunization by irradiated
cells, and the results will be given in the
corresponding section.
TABLE I.-Summary and time table of immunization and tests
Transplanted mice
Amputated mice
Mice immunized with
MTC-treated cells
Mice immunized with
irradiated cells
Transplan-
tation
(Day)
0
Amputa-
tion
(Day)
0 6-8
Immun-
ization
(Day)
Cyto-
toxicity
(Day)
Cyto-
toxicity
after
MLTC
(Day)
Spleno-
cytes
for
WVinn
assay
collected Challenge
(Day) (Day)
15 5 15
(5 after
MLTC)
30 30 30 30
0-7-14 21 21 21 19
_ 0-14
28-42
56-70
77 77 77 75
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TABLE II. Characteristics of cytotoxicity of splenocytes from transplanted mice
(Oo cytotoxicity for 100/1)
Unitreated MBL2 target cells
Incubation with anti-Thy 1-2 + C' inI
MBL2 target cells
Untreated EL4 target cells
Day 8
3-3+0 ,3
ND
Secon(d
stnimulatioIl
MILTC
:38+2t
ND
ND 9 5+ 1-8
Day 15
18-8+ 2.8*
0 7+0 2
1-2+0-4
* Results of 3 experiments with xvariout.s effectors oIn gIrotups of 5 trainsplante(d inice.
t P < 0 05.
ND: not done.
In vitro tests in transplanted mnice
Cytotoxicity. Cytotoxicity was maxi-
mal on Day 15. This cytotoxicity was Ag-
specific and T-cell associated (Table II).
Cytotoxicity was high in splenocytes col-
lected on Day 5 and restimulated in
MLTC, but this second stimulation gener-
ated partial, nonspecific activity (Table I).
Transfer of splenocytes fromt transplanted
mtce
Transfer of splenocytes from tumour-
bearing mice offered no protection against
implanted tumour. Splenocytes were har-
vested from tumour-bearing mice on either
Day 8 of tumour evolution and placed in
MLTC, or simply harvested on Day 15.
This lack ofprotection was consistent with
the fact that the tumour-bearing mice
regularly succumbed to their tumour,
thereby demonstrating a weak or non-
existent immune response, incapable of
halting tumour growth (results from 3
separate experiments; splenocytes for
each experiment were pooled from 5 mice
and subsequently administered to 4 mice).
In vitro tests after immunization by
amputation
Cytotoxicity. Cytotoxicity was never
higher than 5%0 for the 1/100 ratio, when
evaluated 30 days after transplantation
(Fig. IA). However, in vitro restimulation
increased CTL activity. Con A restimula-
tion elicits an increased Ag-specific cyto-
toxic response which is T-cell-associated.
Restimulation in MLTC yielded a cyto-
toxicityhigherthanConA stimulation, but
was not entirely specific (Fig. IB).
In vivo tests after imnmunization by
amputation
Challenge. None ofthe tumour-bearing
mice which underwent successful amputa-
tion developed a second tumour. This
immunization was shown to be specific, for
inoculation of these mice with EL4
tumour cells was followed bv death at the
same time as the control tumour group
(Fig. 2).
WVinn assay. For ratios of 100/1 and
300/1, 66% of the mice showed total pro-
tection (Fig. 3) and never developed a
tumour. This protection was abolished
by anti-Thy 1.2. treatment, and is there-
fore a T-cell-associated phenomenon. It
was further noted that splenocytes which
30/1 50/1 20/1 10/1 30/1 50/1
RATIO SPLENOCMES/BlI2 .RATIO SPLEPOCYTES/EL4
FIG. I. A. T cytotoxicity of splenocytes from
transplanted( amputated mice against the
relevant target (1IMBL2). 30 days after
transplantation (-----), after MNILC2 ( ),
after ConA restimulation (---). B. The
same effectors against irrelevant target
(EL4).
Day 20
2_5+ 1*5
ND
ND
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FIG. 2. Survival of challenge(d animals after
different immunization techniques: Trans-
plantation before amputation ( - ) (3
exp, each one with 5 mice, 3-4 days after
transplantation, AITC-MBL2 immuniza-
tion ( ) (2 exp., each one witlh 5 immun-
ized mice, 1 week after tlhe last booster
injection) irradiate(l AMBL2 immunization
(---) (3 exp., eaclh one with 5 immunizedl
mice, 1 week after the last booster injection).
I SIMlVAL
N ~~~.- -U~ flf
II. I II .I
6_1 __________ Irw M"l
I,_-w-w--F-X
20 2 Si
DAYS
FIG. 3. Survival of different recipients of the
Winn assay. Recipients of splenocytes from
transplanted amputated mice +MBL2 at
the following ratios: 30/1 (. ), 100/1
(- ), 300/1 ( ). Recipients of spleno-
cytes from the same mice boot after AILC2 +
MBL2 at the following ratios: 100/1
(- ), 300/1 (:A =A).
had been subjected to secondary stimula-
tion in MLTC before use, afforded total
protection for the 300/1 mouse group.
In vitro tests after imm,unization by i.p.
injection ofMTC-MBL2 cells
Cell-cytotoxicity.-Although cytotoxicity
was weak (Fig. 4A) there was a noticeable
increase after secondary MLTC.
In vivo tests after MTC-MBL2 cell
immunization
Challenge. Animals immunized by in-
jection of MTC-MBL2 cells never rejected
the challenge (Fig. 2). In one-half of all
animals studied, this type ofimmunization
10 -
I
I
+ '+E
,Ilii
r I I
10/1 30/1 50/1 100/1
RATIO EFFECTOR/TARGET CELLS (MBL2)
Fio. 4.- MTC-MBL2 immunization: T-cyto-
toxicity of splenocytes immediately after
immunization ( ) or after MLC2
(----). Results of 3 exp. where spleno-
cytes were pooled from 5 immunized mice,
one w-eek after the last booster injection.
led to a slight retardation of tumour
growth, which increased survival by a few
days.
IV'inn assay.-Tumour developed in the
experimental animals and the control
group at the same rate.
In vitro tests after imnmunization w.ith
irradiated MBL2 cells
Cytotoxicity. Direct cytotoxicity reach-
ed 25% for the 100/1 ratio (Fig. 5A). This
cytotoxicity is Ag-specific and T-cell-
associated, but did not respond to second-
ary stimulation.
Humoral cytotoxicity (C'DA). C'DA
was noted following the addition of C' to
experimental mouse serum (Fig. 5B).
In vivo tests after immunization by i.p.
injection of irradiated MBL2 cells
Challenge. Immunization with irradi-
ated MBL2 cells totally protected 66%
of the animals (Fig. 2). Seventeen per
cent of the mice showed moderate im-
munity (survival up to 50 days) while the
remaining mice showed no apparent pro-
tection after irradiated-cell administra-
tion. The immunization noted for these
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Z T X C'D CYTOTOXICITY
40i B T
10/1 30/1 100/1 1/8 1/16 1/32 1/64
EFFECTOR/TARGET CELLS (BI-2) SERUM DILUTIONS
FIG. 5. Irradiated MBL2 immunization.
Results of 3 separate exp., each on 5
immunized mice tested one week after the
final booster.
s
100
66
33
VIVN~~~~~~~~~~~~~I
.. .- ,D 20. .D 0,
FEG. 6. Survival of recipients in the Winn
assay with irradiated-MBL2 immunized
splenocytes + MBL2 at the following ratios:
30/1 ( ) 100/1 (- -), 300/1 (--
P < 0-0] for the ratio 300/1. Results of 3 exp.
each with 9 mice, witlh 3 mice per ratio
studied; splenocytes were obtained from 5
immunized mice one week after their last
booster.
mice was not altogether specific; when
they were challenged with EL4 cells, they
showed retarded tumour growth (3-15
days longer than the control group) but
none ofthe mice survived the challenge.
Winn assay.-There was a 33% survival
rate for the 300/1 group (Fig. 6). The other
groups showed an additional 15-32 days
survival over the control group. Further-
more, it was as if cytotoxic activity did
not depend solely on T cells in this par-
ticular instance, since anti-Thy 1-2 serum
did not totally eliminate the lytic activity
of the splenocytes in the assay.
DISCUSSION
We observed that in vitro lysis by
splenocytes from some experimental
groups was not transferable in vivo, and
consequently that a tumour developed
when they were used in the Winn assay.
This test was negative for donor lympho-
cytes obtained from tumour-bearing mice,
transplanted at their peak in vitro cyto-
toxicity. Likewise, although the spleno-
cytes from mice immunized with MTC-
MBL2 were able to differentiate into
active effectors after MLTC, this response
either did not appear to occur in vivo, or
was possibly masked by some other factor.
This immunization was consequently not
capable of effecting tumour-cell rejection.
In contrast, cytotoxic effector cells from
amputated animals, which, in vitro, re-
sponded in the same way as those cells
originating from animals immunized with
MTC-MBL2 cells, acted as protectors in
the Winn test (66% at 300/1 and 100/1;
100% at 300/1) if cells were previously
exposed to a secondary MLTC stimulation.
In addition, comparison of the data
obtained after immunization following
surgical removal ofthe tumour with those
after multiple injections of irradiated cells
strongly suggested that, in the precise con-
text of the former immunization, CTL
were fully capable of cancer-cell lysis in a
situation of adoptive immunity, and very
probably were responsible for rejection of
tumour challenge. Although host protec-
tion was seen after immunization by in-
jection of irradiated MBL2 cells, its
characteristics differed from that in the
amputation group. To begin with, the
protection was not total: 66% rejected
tumour-cell challenge and 33% for the
300/1 ratio rejected the tumour cell
inoculum in the Winn assay (compared
with 100% protection in the amputation
group for both challenge and Winn assay).
Moreover, rejection was not tumour-
specific and the Winn assay was not
entirely T-cell dependent. Although this
method offered significant protection of
the animal, it was less informative for the
identification of the effector involved.
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Indeed in the transfer, CTL are associated
with different lymphocyte and monocyte
populations, particularly macrophages
and/or antibody-synthesizing B lympho-
cytes. And we know that there are pro-
tective antibodies, since we showed that
this immunization induced C'DA.
In view ofthese results several questions
arise: (i) Why are some CTL not in vivo
protectors, since in vitro they behave like
in-vivo-protective CTL from amputed
mice? (ii) How to account for the differ-
ence in response between immunization by
amputation and that arising after injec-
tion of irradiated cells? And (iii) To what
extent are CTL implicated in challenge
rejection when it occurs?
The following comments seem relevant:
(i) CTL in the tumour-bearing mice
were unable to protect against tumour
evolution. This could be due to a dis-
equilibrium in the number and rate of
multiplication ofprotector cells, favouring
the increasing number of tumour cells.
Nevertheless, this point is weakened by
the fact that a favourable ratio (300/1) in
the Winn assay still does not stop tumour
growth. Thus other factors than an over-
whelming number of tumour cells are
needed to explain why these CTL failed to
arrest tumour evolution. Possibly the
environment encountered by these CTL
impeded target-cell recognition, either by
excess antigen acting as blocking factor
(Gerber & Brown, 1973) or antigen modifi-
cation due to necrosis within the tumour
mass. Alteration of the antigen and its
repercussions on in vivo CTL recognition
may also be evoked to explain the in vivo
failure of MTC-MBL2-immunized CTL to
protect against tumour challenge or to
yield favourable results in the Winn assay.
Although a certain level ofrecognition was
obtained in vitro (Fig. 4A) it was not
enough for challenge rejection or for
elimination of tumour cells in the Winn
assay.
(ii) Again it appeared that altered anti-
gen and large quantities ofantigen are the
most plausible explanation for the dis-
crepancy between amputation (T-depen-
dent and antigen-specific absolute protec-
tion) and irradiated cell (not entirely T-
dependent and antigen-specific and offer-
ing only partial protection) immunization
results. Irradiation and absence of multi-
plication may modify the antigen charac-
teristics of tumour cells, leading to a
minor roleforCTLintumour-cell rejection.
On the other hand, repeated injections of
high cell numbers could conceivably draw
in other immunological factors. The in-
volvement of these additional factors may
impede the activity of CTL, which then
respond in a less evident and less specific
fashion, but these factors also may bring
in beneficial effectors such as cytotoxic
antibodies or macrophage (cf. the not
entirely T-dependent response).
An additional difference between ampu-
tation and irradiated-cell immunization
was observed for CTL response in MLTC.
The different MLTC responses among the
different protocols merit analysis and dis-
cussion. When the direct test was negative
(transplanted mice up to Day 8; ampu-
tated mice; immunized mice with MTC-
MBL2) a good post-MLTC cytotoxic re-
sponse was observed. In contrast, the
experimental groups demonstratingacyto-
toxicity when evaluated in the direct test
(transplanted mice at Day 15; immunized
mice with irradiated cells) never developed
a higher cytotoxicity after MLTC. Thus
splenocytes at their maximal cytotoxic
activity will not exhibit increased lysis of
target cells when assayed in MLTC. On the
other hand, pre-killers (sensitized but not
yet lytic, e.g. transplanted mice up to
Day 8) or memory cells (no longer lytic,
e.g. amputated mice) will develop strong
post-MLTC cytotoxic activity.
Other studies support our findings for
secondary response induction: Dunlop et
al. (1977) have shown that sensitized pre-
cytotoxic lymphocytes were already speci-
fically committed to respond to a second
stimulation. Cerottini et al. (1974) showed
that 2 months after i.p. injection of allo-
geneic cells, when the cytotoxic activity
due to the primary response had almost
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completely disappeared, the splenocytes
were able to generate a secondary response
in MLC. The cells appeared to have slowly
lost cytotoxic activity in the absence of
antigenic stimulation, but were able to
differentiate again into effector cells on
secondary stimulation.
By contrast, an explanation for an
absence of secondary response at peak
cytotoxicity has not yet been clearly
established. MacDonald et al. (1974a)
believe that CTL, at their maximum cyto-
toxicity, exist in a differentiated state
which does not allow them to respond to
secondary stimulation. Fitch et al. (1975)
suggest that cytolysis of the stimulating
cell population by the already cytotoxic
responder cells may condition a no-
response situation. Ting et al. (1976b)
found that the absence of secondary re-
sponse was associated only with pro-
gressor animals (Friend virus) and de-
duced that only those animals with a
strong immune reaction were capable of
mounting a secondary response. Our re-
sults with irradiated-cell immunization
contradicts the Ting hypothesis, since our
immunized animals presented a strong
immune response, and yet failed to respond
after MLTC or ConA stimulation. For this
reason, the Macdonald and/or Fitch hypo-
theses should be kept in mind when con-
sidering the case in hand. Of these two
hypotheses we tend to prefer the first,
since pre-killers, mature effectors and
memory cells were shown (Macdonald et
at., 1974b) to exist in different stages of
cellular differentiation, where precursors
and memory cells are high-density small
lymphocytes and effectors are character-
ized as large, lower-density lymphocytes.
Possibly only dense small lymphocytes
develop a secondary response.
(iii) If we compare the data after im-
munization following amputation and
after multiple injections of irradiated
cells, we can reasonably assume the active
role played by CTL in the in vivo rejection
oftumour cells, at least in the former case.
Previous studies (Ting et al., 1976a;
Glaser et al., 1976) have shown that
lymphocytes were protective in adoptive
transfer, but correlation with in vitro
cytotoxicity was not always conclusive,
though these observations were made in
viral systems. In our system, which is
100% lethal and not a virus producer, it
was found, by using different immuniza-
tion procedures, that when cytotoxicity
was not completely T-dependent, the
splenocytes in the Winn assay were not
totally protective and the rejection of the
challenge was not absolute and not strictly
tumour-specific (as in the case ofimmuniz-
ation by irradiated cells). On the contrary,
when T-dependent cytotoxicity existed, all
the cancer cells were destroyed in the
Winn assay, and rejection of the challenge
occurred in all cases and was specific
for the antigen. AVe also demonstrated
identical kinetics between in vivo and
in vitro assays, as very recently re-
ported by Bosslet et al. (1979) since the
splenocytes were the most protective in
the Winn assay after the secondary
stimulation, exactly as in tumour chal-
lenge, which is a secondary stimulation
for the transplanted-amputated mice.
In addition we have shown elsewhere
(Pioch et al., 1979) that our system
did not possess natural killers against
MBL2 target cells, and that when non-T-
killer cells were induced after BCG treat-
ment they were not protective in the Winn
assay. Formal proof would require the use
of more purified populations (i.e. obtained
after cloning or positive selection using
Lyt 2 antiserum) on one hand, and sys-
temic injection on the other.
The data reported here provide several
lines of evidence which strongly suggest
that: (a) CTL may be actually specifically
and exclusively involved in tumour rejec-
tion, within a well-defined context; and (b)
nevertheless, different tumour situations
may benefit from less specific immuno-
therapies involving other factors of the
immutne response.
W'e greatly appreciate the excellent techlnical
assistance of C. Gonidral and A. Sautou. This work
was stipporte(t by ATP CNRS 2891 and INSERM
Contract No. 77-4-0832.
282SIGNIFICANCE OF CTL AFTER VARIOUS IMMUNIZING PROCEDURES 283
REFERENCES
BENJAMINI, E., FONG, S., ERICKSON, C., LEUNG,
C. Y., RENNICK, D. & SCIBIENSKI, R. J. (1977)
Immunity to lymphoid tumors induced in syn-
geneic mice by immunization with mitomycin
C-treated cells. J. Immunol., 118, 685.
BOSSLET, K., SCHIRRMACHER, V. & SHANTZ, G. (1979)
Tumor metastases and cell-mediated immunity
in a model system in DBA/2 mice. VI: Similar
specificity patterns of protective anti-tumor
immunity in vivo and of cytolytic T cells in vitro.
Int. J. Cancer, 24, 303.
CARLSON, G. A. & TERRES, G. (1976) Antibody-
induced killing in vivo of L1210/MTX-R cells
quantitated in passively immunized mice with
1311-iododeoxy-uridine-labelled cells and whole-
body measurement of retained radioactivity J.
Immunol., 117, 822.
CEROTTINI, J. C. & BRUNNER, K. T. (1971) In vitro
assay of target cells lysis by sensitized lympho-
cytes: In In Vitro Methods in Cell-Mediated
Immunity. Eds Bloom & Glade. New York:
Academic Press. p. 369.
CEROTTINI, J. C., ENGERS, H. D., MACDONALD, H. R.
& BRUNNER, K. T. (1974) Generation of cytotoxic
T lymphocytes in vitro. J. Exp. Med., 140, 703.
CREIGHTON, W. D., LAMBERT, P. H. & MIESCHER,
P. A. (1973) Detection of antibodies and soluble
antigen-antibody complexes by precipitation with
polyethylene glycol. J. Immunol., I11, 1219.
DUNKLEY, M., MILLER, R. G. & SHORTMAN, K.
(1974) A modified 51Cr release assay for cytotoxic
lymphocytes. J. Immunol. Methods, 6, 39.
DUNLOP, M. B. C., DOHERTY, P. C., ZINKERNAGEL,
R. M. & BLANDEN, R. V. (1977) Cytotoxic T cell
response to lymphocytic choriomeningitis virus:
Properties of precursors ofeffector T cells, primary
effector T cells and memory T cells in vitro and
in vivo. Immunology, 33, 361.
FITCH, F. W., ENGERS, H. D., MACDONALD, H. R.,
CERROTTINI, J. C. & BRUNNER, K. T. (1975)
Generation of cytotoxic T lymphocytes in vitro.
VI: Effect of cell density on response in mixed
leucocyte cultures. J. Immunol., 115, 1688.
GERBER, M. J. & BROWN, E. R. (1973) In vivo and
in vitro evaluation of immune response of hamster
to immunization and transplants of autoch-
thonous reticulum cell sarcoma. Cancer Res., 33,
3029.
GHAFFAR, A., CALDER, E. A. & IRVINE, W. J. (1976)
K cell cytotoxicity against antibody-coated
chicken erythrocytes in tumor-bearing mice: its
development with progressively growing tumor
and the effect ofimmunization against the tumor.
J. Immunol., 116, 315.
GLASER, M., LAVRIN, D. H. & HERBERMAN, R. B.
(1976) In vivo protection against syngeneic Gross
virus-induced lymphoma in rats: Comparison
with in vitro studies of cell-mediated immunity.
J. Immunol., 116, 1503.
GLYNN, J. P., McCoy, J. L. & FEFER, A. (1968)
Cross-resistance to the transplantation of syn-
geneic Friend, Moloney, and Rauscher virus-
induced tumors. Cancer Res., 28, 434.
GoRCZYNSKI, R. M., MILLER, R. G. & PHILLIPS, R. A.
(1972) Initiation of antibody production to sheep
erythrocytes In vitro: Replacement ofthe reqtuire-
ment forT-cells with acell-free factorisolated from
cultures of lymphoid cell. J. Immunol., 108, 547.
HUNNINGHAKE, G. W. & FAucI, A. S. (1976) Quanti-
tative and qualitative effects ofcyclophosphamide
administration on circulating polymorphonuclear
leucocytes. Immunology, 31, 139.
LECLERC, J. C., GOMARD, E., PLATA, F. & LEVY,
J. P. (1973) Cell-mediated immune reaction against
tumors induced by oncorna-viruses. II. Nature of
the effector cells in tumor-cell cytolysis. Int. J.
Cancer, 11, 426.
LEVY, J. P. & LECLERC, J. C. (1977) The murine
sarcoma virus-induced tumor: exception or general
model in tumor immunology? Adv. in CancerRes.,
24, 1.
MACDONALD, H. R., ENGERS, H. D., CEROTTINI,
J. C. & BRUNNER, K. T. (1974a) Generation of
cytotoxic T lymphocytes in vitro. II: Effect on
repeated exposure to alloantigens on the cytotoxic
activity of long-term mixed leucocyte cultures.
J. Exp. Med., 140, 718.
MACDONALD, H. R., CEROTTINI, J. C. & BRUNNER,
K. T. (1974b) Generation of cytotoxic T lympho-
cytes in vitro. III: Velocity sedimentation studies
of the differentiation and fate of effector cells in
long term mixed leukocytes cultures. J. Exp. Med.,
140, 1511.
NEGRONI, G. & HUNTER, E. (1971) Antigenic hetero-
geneity in cell populations of cloned polyoma
virus-induced tumor lines. Nature (New Biol.),
230, 18.
PIOCH, Y., GERBER, M. & SERROU, B. (1979) Natural
killer-like activity induced in spleen by IP injec-
tion ofBCG. CancerImmunol. Immunother.,7, 181.
ROBERTSON, H. T. & BLACK, P. H. (1969) Changes in
surface antigens of SV40-virus transformed cells.
Proc. Soc. Exp. Biol. Med., 130, 363.
THIERRY, C., FLORES, G., CARAUX, J., VALLES, H. &
SERROU, B. (1976) Techniques de s6paration et
de caract6risation de sous-populations lympho-
cytaires chez l'homme. In Techniques ofSeparation
and Characterization of Human Lymphocytes. Vol.
57. Eds Sabolovic & Serrou. Paris: INSERM
p. 15.
THIERRY, C. & SERROU, B. (1974) Microtechnique de
stimulation blastique des lymphocytes chez
l'homme. In La Stimulation Blastique des Lympho-
cytes par les MitogAnes. Application aux Lympho-
cytes Humains et Murins. Vol. 35. Ed. Serrou.
Paris: INSERM. p. 35.
TING, C. C., RODRIGUES, D., BUSHR, G. S. & HERBER-
MAN, R. B. (1976a) Cell-mediated immunity to
Friend virus-induced leukemia. II: Characteristics
of primary cell-mediated cytotoxic response.
J. Immunol., 116, 236.
TING, C. C. & BONNARD, G. D. (1976b) Cell-mediated
immunity to Friend virus-induced leukemia. IV:
In vitro generation of primary and secondary cell-
mediated cytotoxic response. J. Immunol., 116,
1419.
WERNET, D. & LILLY, F. (1975) Genetic regulation of
the antibody response to H-2Db alloantigens in
mice. J. Exp. Med., 141, 573.
WINN, H. J. (1961) Immune mechanisms in homo-
transplantation. II: Quantitative assay of the im-
munologic activity of lymphoid cells stimulated
by tumorhomografts. J. Immunol., 86, 228.
WYSS, P. & CEROTTINI, J. C. (1976) Mise en 6vidence
quantitative de l'activite K chez l'homme. In
Techniques of Separation and Characterization of
Human Lymphocytes. Vol. 57. Eds Sabolovic and
Serrou. Paris: INSERM. p. 235.